STOCK TITAN
  1. Home
  2. Sec-filings
  3. GH
  4. [144] Guardant Health, Inc. SEC Filing

[144] Guardant Health, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock GH logo
Guardant Health

NASDAQ:GH

GH Rankings

#1059 Ranked by Market Cap
N/A Ranked by Dividends

GH Latest News

Oct 9, 2025
Guardant Health to Report Third Quarter 2025 Financial Results on October 29, 2025
Sep 29, 2025
FDA Approves Guardant360® CDx as Companion Diagnostic for Eli Lilly and Company’s Inluriyo™ (imlunestrant) for Treatment of ESR1-mutated Advanced Breast Cancer
Sep 24, 2025
Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant’s Shield™ Blood-based Screening Test in the United States
Sep 15, 2025
Alex M. Azar II Joins Guardant Health Board of Directors
Sep 11, 2025
Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida Partnership

GH Latest SEC Filings

Oct 2, 2025
[Form 4] Guardant Health, Inc. Insider Trading Activity
Oct 2, 2025
[Form 4] Guardant Health, Inc. Insider Trading Activity
Oct 2, 2025
[Form 4] Guardant Health, Inc. Insider Trading Activity
Oct 2, 2025
[Form 4] Guardant Health, Inc. Insider Trading Activity
Sep 26, 2025
[Form 4] Guardant Health, Inc. Insider Trading Activity

GH Stock Data

8.15B
119.27M
4.5%
99.11%
6.43%
Diagnostics & Research
Services-medical Laboratories
Link
United States
PALO ALTO